Meta tags:
Headings (most frequently used words):
other, latvia, ukraine, slovenia, slovakia, serbia, russia, malta, lithuania, lebanon, jordan, markets, israel, iceland, egypt, estonia, croatia, bulgaria, herzegovina, and, bosnia, venezuela,
Text of the page (most frequently used words):
#methodology (34), #efpia (34), #document (30), 2021 (25), 2020 (20), 2022 (19), our (16), #english (14), #documents (14), #transparency (14), tel (11), com (11), #icon (10), #page (9), swixxbiopharma (9), #info (9), biopharma (8), next (7), swixx (7), quick (7), and (7), links (7), research (7), business (7), spanish (6), medicines (6), the (6), squibb (5), #israel (5), report (5), myers (5), about (5), bristol (5), information (5), contact (5), french (4), united (4), access (4), telephone (4), resources (4), drug (4), development (4), investors (4), markets (4), other (4), global (4), position (3), leadership (3), media (3), slovenia (3), for (3), medical (3), history (3), areas (3), latvia (3), annual (3), bulgaria (3), german (3), croatia (3), estonia (3), slovakia (3), serbia (3), office (3), egypt (3), malta (3), lithuania (3), pacific (3), jordan (3), lebanon (3), request (3), patient (3), researchers (3), careers (3), providers (3), venezuela (3), healthcare (3), news (3), patients (3), caregivers (3), company (3), stories (3), interest (2), 961 (2), learn (2), notice (2), center (2), beirut (2), 2024 (2), team (2), serdika (2), iceland (2), bosnia (2), herzegovina (2), previous (2), arabic (2), releases (2), press (2), chinese (2), system (2), pharma (2), trials (2), vistor (2), main (2), floor (2), stock (2), 385 (2), clinical (2), box (2), 2078 (2), post (2), study (2), shareholders (2), http (2), pre (2), approval (2), mangion (2), russia (2), portuguese (2), statement (2), contacts (2), czech (2), publications (2), bms (2), locations (2), commitment (2), worldwide (2), inclusion (2), diversity (2), ukraine (2), dutch (2), 381 (2), from (2), states (2), countries (2), amicus (2), 4426 (2), partners (2), celgene (2), distributor (2), split, calculator, return, innovation, investment, filings, dividend, results, quarterly, summary, golden, sec, 2023, sustainability, meetings, investor, simplified, acquisition, related, shareholder, close, services, skip, asia, events, presentations, analyst, week, responsibility, product, sales, scientific, alliances, peru, begin, mexico, discussion, china, brochure, australia, why, colombia, partner, with, partnerships, infographics, early, canada, americas, ticket, archive, reports, argentina, brazil, chile, library, contests, corporate, download, meeting, disease, state, coverage, italy, financial, emirates, belgium, east, middle, hebrew, arabia, saudi, turkey, austria, turkish, europe, arab, kingdom, thai, thailand, bmsuscqpagelucene, your, paying, help, traditional, get, rems, strategies, republic, denmark, evaluation, germany, luxembourg, netherlands, ireland, norway, norwegian, poland, hungarian, hungary, greek, greece, france, danish, finnish, polish, portugal, romania, romanian, spain, finland, sweden, swedish, switzerland, mitigation, risk, reporting, grants, incubator, daniel, thomas, head, perspectives, japanese, disclosure, portal, italian, investigator, japan, independent, competitive, requests, technology, compound, process, india, sharing, data, medicine, translational, collaboration, korea, immunology, singapore, drugs, taiwan, generic, pricing, world, around, today, psoriasis, sheet, fact, practice, efforts, new, 340b, zealand, korean, focus, pipeline, voices, expert, stem, sponsored, fra, survivorship, milorada, building, ammangion, srb, 301, 300, belgrade, 911000, jovanovica, 600, valletta, 20833, 421, 821, bratislava, blok, prievozská, centre, off, road, regus, riga, 18a, iela, valdemara, ras, oueyni, hussein, 788976, 806640, email, net, luqa, terra, uab, 9140, 236, 370, vilnius, bokšto, ltd, 6000, lqa, apollo, 100, 1010, privacy, intermedia, planta, oficina, representación, casa, drovital, navigation, home, legal, trademarks, financiera, looking, forward, pdf, trafficking, human, slavery, follow, january, torre, avenida, 2355, 386, črnuče, ljubljana, 351231, sejmišču, pot, 3202, 751, 212, drovitalcr, beethoven, berrios, blanca, caracas, metropolitana, área, baruta, municipio, monte, bello, colinas, urbanización, 371, technologies, 4942, bih, 810, 257, 387, sarajevo, 71000, zvizdovića, anđela, eood, 480, 359, multinational, sofia, 1505, mall, 10th, blvd, sitnyakovo, group, serviced, sterling, 508, 500, 10000, party, timeline, foundation, groups, resource, people, issues, key, menu, down, drop, third, operate, please, local, have, not, does, where, many, through, directly, either, zagreb, 67708347, amman, 3361, bart, aharon, 5231021, 972, store, orient, 11118, gharbi, arye, weibdeh, jabal, edwan, nimer, 590, 2000, 465, sia, kiryat, petah, savska, 1030, 640, 372, tallinn, 10145, tornimäe, medscience, fattal, cairo, flat, tikva, 6th, heliopolis, almaza, elhoreya, 20224146784, island, gardabear, 210, horgatun, 4951448, content,
Text of the page (random words):
other markets bristol myers squibb our medicines our stories investors skip to main content contact us careers united states close icon americas argentina spanish brazil portuguese canada english french chile spanish colombia spanish mexico spanish peru spanish united states english asia pacific australia english china simplified chinese india english japan japanese korea korean new zealand english singapore english taiwan traditional chinese thailand english thai europe austria german belgium english dutch french czech republic czech denmark danish finland finnish france french germany german greece greek hungary hungarian ireland english italy italian luxembourg english netherlands english dutch norway norwegian poland polish portugal portuguese romania romanian spain spanish sweden swedish switzerland german french united kingdom english middle east israel hebrew saudi arabia english arabic turkey turkish united arab emirates english arabic other other markets distributor markets bmsuscqpagelucene medicines careers press releases medical information previous page icon previous page icon our medicines patients caregivers next page icon patients caregivers our medicines get help paying for your medicines patient resources risk evaluation and mitigation strategies rems quick links immunology patient resources our position on generic drugs our position on drug pricing psoriasis around the world healthcare providers next page icon healthcare providers learn about pre approval access learn about post study drug access 340b practice fact sheet quick links u s medical information clinical trials pre approval access request system post study drug access request system researchers next page icon researchers areas of focus in the pipeline r d expert voices our efforts in stem clinical trials research independent research the thomas o daniel research incubator and collaboration center quick links perspectives from our head of research research publications disclosure commitment investigator sponsored research portal areas of interest competitive research grants compound technology requests data sharing request process translational medicine investors next page icon investors stock information financial reporting analyst coverage events and presentations shareholder services acquisition related information for celgene shareholders investor contacts quick links annual report 2023 dividend history stock split history investment return calculator sec filings quarterly results product sales summary annual reports archive annual meeting of shareholders business development next page icon business development our partnerships why partner with us areas of interest business development leadership team begin a discussion global alliances leadership team early innovation at bms quick links download business development brochure golden ticket contests news next page icon news press releases our stories medical meetings media library media contacts quick links scientific media resources disease state infographics corporate publications about us next page icon about us our company leadership global inclusion diversity responsibility sustainability contact us quick links global patient week survivorship today our technologies history timeline worldwide locations the bristol myers squibb foundation people business resource groups our commitment to global inclusion and diversity position on key issues other markets as a multinational biopharma company we operate either directly or through distributor partners in many countries for contact information in the countries where bristol myers squibb does not have a local office please contact our third party business partners from the drop down menu bosnia and herzegovina bulgaria croatia egypt estonia iceland jordan israel latvia lebanon lithuania malta russia serbia slovakia slovenia venezuela ukraine bosnia and herzegovina amicus pharma d o o fra anđela zvizdovića 1 71000 sarajevo tel 387 33 257 810 bih info swixxbiopharma com transparency documents efpia 2021 methodology document 2021 bulgaria swixx biopharma eood sterling serviced office group 48 sitnyakovo blvd serdika center 10th floor serdika mall 1505 sofia tel 359 2 4942 480 bulgaria info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 croatia swixx biopharma d o o savska 32 10000 zagreb tel 385 1 2078 500 tel 385 1 2078 508 croatia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 estonia swixx biopharma oü tornimäe 5 2 10145 tallinn tel 372 640 1030 estonia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 egypt fattal office medscience 48 elhoreya st almaza heliopolis 6th floor flat 12 cairo egypt telephone 20224146784 iceland vistor horgatun 2 210 gardabear island http vistor is transparency documents efpia 2021 methodology document 2021 israel bristol myers squibb israel 18 aharon bart st po box 3361 kiryat arye petah tikva 4951448 israel telephone 972 3 5231021 jordan orient drug store p o box 590 nimer el edwan st jabal el weibdeh el gharbi amman 11118 jordan telephone 96 26 465 2000 latvia swixx biopharma sia valdemara iela 33 18a riga lv 1010 tel 371 67708347 latvia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 lebanon pacific pharma hussein oueyni st ras beirut beirut lebanon telephone 961 1 806640 961 1 788976 email pacific terra net lb lithuania swixx biopharma uab bokšto 1 3 vilnius tel 370 5 236 9140 lithuania info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 malta a m mangion ltd mangion building n s off valletta road luqa lqa 6000 malta http ammangion com mt transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 russia bms transparency documents efpia 2022 methodology report efpia 2021 methodology report efpia 2020 methodology report celgene transparency documents efpia 2020 methodology report serbia amicus srb d o o milorada jovanovica 911000 belgrade tel 381 11 4426 300 tel 381 11 4426 301 serbia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 slovakia swixx biopharma s r o regus apollo business centre prievozská 4d blok e bratislava 821 09 tel 421 2 20833 600 slovakia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 slovenia swixx biopharma d o o pot k sejmišču 351231 ljubljana črnuče tel 386 1 2355 100 slovenia info swixxbiopharma com transparency documents efpia 2022 methodology document 2022 efpia 2021 methodology document 2021 efpia 2020 methodology document 2020 ukraine transparency documents efpia 2021 methodology document 2021 venezuela drovital casa de representación c a oficina a planta intermedia torre financiera avenida beethoven urbanización colinas de bello monte municipio baruta área metropolitana de caracas venezuela 58 212 751 3202 blanca berrios drovitalcr com main navigation home patients caregivers healthcare providers researchers investors news about us resources our medicines legal notice privacy notice trademarks forward looking statement uk ca slavery and human trafficking statement pdf follow us careers our stories contact us worldwide locations january 07 2024 2024 bristol myers squibb company
|